By the way, I am by no means anything near an expert in investing, and I am learning as I go, and trying as best as I can to be patient and positive with all my investments.
This is not necessarily a good analogy, but if you look at the biotechnology stocks, many of these (I am invested in AMLN, so it falls into this category) show virtually no revenues, because they are involved exclusively in R&D. They are putting their resources into a product that they hope to get FDA approval on what it is they develop, and when and if that happens, BANG, the stock will rise.
So HR, when you mention R&D, that is what comes to my mind. Unfortunately, everyone gets into a stock at one point or another. In this stock, some are in high, and they will have to wait even longer to get even. I am not in that high (.22), so I know that my patience will one day reward me, because I believe, like you and Ga Bard that this company's day will come when their products will yield great revenues and net income. The volume alone is enough to encourage me.
I am in a similar situation with CBNR. There are investors there who paid up to $2. The stock went into the toilet, I bought it at .26, I think that it will go back to $2 and beyond. Now it is trading .45-.50. Of course, I am happy, it spiked earlier in the week and the daytraders made a killing when the bid got up to .65. I held most of my position, because I want to maximize the profit, the stock can go higher, as I said before, I look for bigger rewards for my patience. But I guess my point is that when you talk to the ones who paid $2, they are still bitter. Sometimes, it is hard to heal wounds.
HR, thanks for your efforts to keep things positive, that is where I think it belongs, and I hope everyone will now follow your lead.
May peace be with you,
David |
